Experimental study in vivo had demonstrated that decreased HR efficiency could lead to breast cancer progression (87) However, whether RAD51 was acetylated by HDAC2 or SIRT2 was not discussed in detail. This evidence concerns the gene SIRT2 and breast carcinoma.